Le Lézard

NAYA Announces Partnership with Alpha Nuclide to Support Clinical Development in China for Its GPC3-Targeting Astatine-211 Alpha Therapy for HCC

Alpha Nuclide's Research & Manufacturing Capabilities to Unlock Access to China Market, Targeting Clinical Trials for NY-703 ...
Le Lézard

Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative ...

Boehringer Ingelheim and Click Therapeutics today shared data from the pivotal Phase III CONVOKE study (NCT05838625) of CT-155 (BI 3972080), an investigational prescription digital therapeutic ...
Le Lézard

U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease

AbbVie today announced the U.S. Food and Drug Administration (FDA) approval of a supplemental new drug application (sNDA) that updates the indication statement for RINVOQ® (upadacitinib) for the ...
Le Lézard

Trialbee and Bristol Myers Squibb to Showcase Advancements in Technology-Driven Patient Recruitment for Last Mile Support at SCOPE Summit Europe

Trialbee, the global leader in technology-driven patient recruitment, will showcase how top pharmaceutical companies are enhancing the way patients connect with sites at SCOPE Summit Europe in ...
Le Lézard

ACHP Receives $4.2M Grant to Improve Diabetes Care and Outcomes from the Helmsley Charitable Trust

Foundation and four of its member health will pilot models to expand access to care for millions living with diabetes, thanks to a $4.2 million grant from The Leona M. and Harry B. Helmsley ...
Le Lézard

Milu Health and Tokio Marine HCC - A&H Group Partner to Provide Self-Funded Plans with Opportunity to Positively Impact Members' Healthcare Experience in Real Time

Milu Health, Inc. a digital healthcare provider focused on leveraging electronic health record data to help patients identify major health issues and get access to high quality care, today announced a ...
Le Lézard

ShapeScale Launches First AI-Driven 3D Body Scanner Delivering Visual, Localized Feedback for the GLP-1 & Biohacking Era

ShapeScale today launches out of beta after testing in 500+ clinics, introducing the first AI-powered, medical-grade 3D body scanner designed for the $100B GLP-1 revolution and surging biohacking ...
Le Lézard

NORD Breakthrough Summit Features Bold New Ideas for the Future of Rare Disease Care, Policy and Research

The future of rare disease advancements will take center stage at the National Organization for Rare Disorders (NORD®) Rare Disease and Orphan Products Breakthrough Summit®, Oct. 19-21 in ...
Le Lézard

CLINIQUE LA PRAIRIE DEBUTS CLP HOLISTIC HEALTH LONGEVITY SUPPLEMENTS IN THE UNITED STATES WITH EXCLUSIVE LAUNCH AT BERGDORF GOODMAN

Clinique La Prairie, the world-renowned Swiss pioneer in longevity, health, and wellness, proudly announces the U.S. retail debut of its core line of longevity supplements, branded CLP HOLISTIC HEALTH ...
Le Lézard

Americans want to embrace new opportunities in retirement, but financial and physical wellness lag

A new report from The Guardian Life Insurance Company of America® (Guardian) reveals that Americans' shifting lifestyles are reshaping ...
Le Lézard

EveryLife Expands Mission with Launch of Pure and Purposeful Feminine Care Line

EveryLife, America's fastest-growing pro-life diaper company, is honored to announce the launch of EveryLife Women, a thoughtfully designed line of premium feminine care essentials created to support ...
Le Lézard

Two Unions Representing Caregivers at the State's Psychiatric Hospitals Release Report Exposing the Degradation in Care for All Patients Due to Inappropriate Admission and ...

The Massachusetts Nurses Association and SEIU 509, two unions representing RNs, healthcare professionals, social workers and mental health counselors at state-operated psychiatric hospitals today are ...